Big Pharma Smoke Screen/Diversion:
The recent PR's about big Pharma Immunotherapies appear to be a diversion and preparation for any good news about DCVax-L and Direct and possibly other related approaches from other smaller companies that are well along.
Unfortunately, the idea of injecting the tumor before removing it does make some sense to me. That is, if they wait for many DC's to migrate out of the tumor on the way to the lymph nodes prior to removal.
Maybe.
The other PR barrage from big pharma has been about PD-L1 inhibitors. Those too sounded like a panacea when I first heard about them. But when I looked up actual clinical results off the web, I gained another impression. So... It is very easy to tout a new untested therapy. It is another to fully develop it and prove it out.
Further, if DCVax-Direct works well, then they may have leap-frogged this other process of injecting the tumor before removal. And as a half-way approach between Direct and L, I don't know that NWBIO would not have the rights to use a similar procedure if L and Direct were both approved. They may have such plans for cases where the tumor can and should be removed.
I think big Pharma is scared. I just hope they don't get underhanded.
News 
Market Data 
Discover 
